Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Rizzotto

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBCJoseph Mills, Anna Tessari, Vollter Anastas, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Cell Death Discovery|April 13, 2025
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Shuxin Dong, Anna Tessari, et al.
Nature Communications|August 5, 2022
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancersTom Van Nyen, Mélanie Planque, Lilian van Wagensveld, et al.
Nature Cancer|February 5, 2022
Downregulation of the FTO m<sup>6</sup>A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitorsJana Jeschke, Evelyne Collignon, Clémence Al Wardi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncotarget|October 3, 2015
HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideAlessandro Canella, Hector Cordero Nieves, Douglas W Sborov, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Nucleolin acute degradation reveals novel functions in cell cycle progression and division in TNBCJoseph Mills, Anna Tessari, Vollter Anastas, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
An <i>in vivo</i> "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Anna Tessari, Arturo Orlacchio, et al.
Cell Death Discovery|April 13, 2025
An in vivo "turning model" reveals new RanBP9 interactions in lung macrophagesYasuko Kajimura, Shuxin Dong, Anna Tessari, et al.
Nature Communications|August 5, 2022
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancersTom Van Nyen, Mélanie Planque, Lilian van Wagensveld, et al.
Nature Cancer|February 5, 2022
Downregulation of the FTO m<sup>6</sup>A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitorsJana Jeschke, Evelyne Collignon, Clémence Al Wardi, et al.
Pageof 4